The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril 2018 Mar;109(3):429-436
Date
03/24/2018Pubmed ID
29566854DOI
10.1016/j.fertnstert.2018.01.002Scopus ID
2-s2.0-85044039055 (requires institutional sign-in at Scopus site) 241 CitationsAbstract
The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations.
Author List
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org, Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive TechnologyAuthor
Jay I. Sandlow MD Chair, Professor in the Urologic Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AneuploidyConsensus
Female
Fertilization in Vitro
Genetic Testing
Humans
Predictive Value of Tests
Pregnancy
Pregnancy Complications
Pregnancy Outcome
Preimplantation Diagnosis
Reproductive Medicine
Risk Assessment
Risk Factors